Rapamycin, a specific inhibitor of mTOR, prevented naïve T-cell activation and induced tolerance of alloreactive T cells, significantly improving the survival, as well as decreasing the GVHD development in mice (19, 44). The gene discussed is MTOR; the disease is graft versus host disease.